Last reviewed · How we verify

Placebo drug of Myonal Tab.

Daewon Pharmaceutical Co., Ltd. · Phase 3 active Small molecule

Placebo drug of Myonal Tab. is a Small molecule drug developed by Daewon Pharmaceutical Co., Ltd.. It is currently in Phase 3 development for Control arm in Phase 3 clinical trials for muscle relaxation/spasticity (indication of active Myonal comparator).

As a placebo, this drug contains no active pharmaceutical ingredient and produces no mechanistic effect beyond the placebo response.

As a placebo, this drug contains no active pharmaceutical ingredient and produces no mechanistic effect beyond the placebo response. Used for Control arm in Phase 3 clinical trials for muscle relaxation/spasticity (indication of active Myonal comparator).

At a glance

Generic namePlacebo drug of Myonal Tab.
SponsorDaewon Pharmaceutical Co., Ltd.
ModalitySmall molecule
Therapeutic areaMusculoskeletal/Neurology (as comparator for Myonal)
PhasePhase 3

Mechanism of action

A placebo is an inert substance used as a control in clinical trials to establish the true efficacy of an active drug by comparison. In Phase 3 trials, placebos help distinguish genuine pharmacological effects from psychological or natural disease progression effects. This particular placebo is used as a comparator for Myonal (eperisone), a muscle relaxant.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Placebo drug of Myonal Tab.

What is Placebo drug of Myonal Tab.?

Placebo drug of Myonal Tab. is a Small molecule drug developed by Daewon Pharmaceutical Co., Ltd., indicated for Control arm in Phase 3 clinical trials for muscle relaxation/spasticity (indication of active Myonal comparator).

How does Placebo drug of Myonal Tab. work?

As a placebo, this drug contains no active pharmaceutical ingredient and produces no mechanistic effect beyond the placebo response.

What is Placebo drug of Myonal Tab. used for?

Placebo drug of Myonal Tab. is indicated for Control arm in Phase 3 clinical trials for muscle relaxation/spasticity (indication of active Myonal comparator).

Who makes Placebo drug of Myonal Tab.?

Placebo drug of Myonal Tab. is developed by Daewon Pharmaceutical Co., Ltd. (see full Daewon Pharmaceutical Co., Ltd. pipeline at /company/daewon-pharmaceutical-co-ltd).

What development phase is Placebo drug of Myonal Tab. in?

Placebo drug of Myonal Tab. is in Phase 3.

Related